Bioceres Crop Solutions Corp. (NASDAQ:BIOX)
| Market Cap | $11.04M-88.8% |
| Revenue (ttm) | $222.77M-28.2% |
| Net Income | -$232.74M-312.8% |
| EPS | -$3.62-331.4% |
| Shares Out | 63.82M |
| PE Ratio | n/a |
| Forward PE | 0.31 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 130,225 |
| Open | $0.18 |
| Previous Close | $0.18 |
| Day's Range | $0.16 - $0.18 |
| 52-Week Range | $0.16 - $1.73 |
| Beta | 0.47 |
| Analysts | Buy |
| Price Target | $2.00(+1056.07%) |
| Earnings Date | Feb 10, 2027 |
About BIOX
Bioceres Crop Solutions Corp. (BIOX) is a company dedicated to enhancing agricultural output through a diverse range of solutions. Its operations are organized into three principal divisions. The Seed and Integrated Products segment is responsible for creating and bringing to market cutting-edge seed technologies, genetic material, biotechnological innovations, and specialized seed coatings. Under its Crop Protection segment, the company formulates, manufactures, and distributes a comprehensive array of products, including Rizoderma, various adjuvants, therapeutic agents, weed killers, insect eradicators, fungal treatments, and pest lures. The Crop Nutrition unit focuses on the development, production, and distribution of inoculants, bio-stimulants, and both organic and micro-granular fertilizers. A notable offering from Bioceres is HB4, an innovative seed technology engineered for drought resistance. The enterprise maintains a significant presence across several countries, including Argentina, Uruguay, France, and South Africa, alongside broader international operations. Established in 2001, the firm's main offices are situated in Rosario, Argentina. Bioceres Crop Solutions Corp. functions as a subsidiary entity under the umbrella of Bioceres LLC.
Next catalysts
- Feb 10, 2027Earnings report
$BIOX stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in BIOX holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by BIOX's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
BIOX Estimated quarterly lobbying spending
Source: U.S. Senate LDA
BIOX Revenue by Segment or Geography
Source: SEC EDGAR (10-Q/10-K)
U.S. Patents
New BIOX patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to BIOX from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in BIOX
| ARGTGlobal X - MSCI Argentina ETF | $233.69K |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from BIOX’s recent data — informational, not investment advice
What’s Behind the Score
Recent Insider Activity
Frequently Asked Questions
ETFs that hold this stock
| ARGT | Global X - MSCI Argentina ETF | 0.04% |
Weight is the stock’s share of each fund’s holdings.
